A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder

NCT05941442 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

80

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor terminated due to significant enrollment and study design challenges

Conditions

Panic Disorder

Interventions

DRUG: Darigabat
DRUG: Placebo

Sponsor

AbbVie